Jul
2026
QSNCC, Bangkok, Thailand
Visit us
stand H01

ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.

Exhibitor at CPHI South East Asia 2026
About Us

Hisun Pharmaceutical was established in 1956. The company manufactures over 100 APIs, with a focus on oncology, anti-infectives, cardiovascular health, immunosuppressants, and animal healthcare. Hisun has built a robust technology platform offering CMO/CDMO services in both fermentation and synthetic processes. With world-class fermentation capabilities—from strain development to large-scale production, Hisun leveraged its pharmaceutical expertise in microbial fermentation to support the nutraceuticals, dietary supplements, and cosmetics sectors.


Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    5000+
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Veterinary Company
Primary activities
Animal Health
API Producer
Biopharmaceutical
Contract Manufacturer
Cosmetic Ingredients
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Intermediates Manufacturer
Nutraceuticals
Pharmaceutical Company (generic finished products)
Contact info
Show contact info Hide contact info
Event information
CPHI South East Asia 2026
  • 08 Jul 2026 - 10 Jul 2026
  • QSNCC, Bangkok, Thailand
  • Visit us at stand H01

Products Featured at CPHI South East Asia 2026

  • Acarbose

    Product Acarbose

    Antidiabetic AgentsJP, USP, EP, ChP, IP
    USDMF, CEP, JDMF, CDE(A)
  • Orlistat

    Product Orlistat

    OTC weight-reducing drug
    USP
    EDMF, CDE(A)
  • Tigecycline

    Product Tigecycline

    Anti-infective APIUSP, EP, YBY
    USDMF, CEP(SUBMITTED), CDE(A)
  • Meropenem

    Product Meropenem

    Anti-infective APIUSP, JP, ChP
    JDMF, CDE(A)
  • Isepamicin Sulfate

    Product Isepamicin Sulfate

    Anti-infective APIChP+YBH
    CDE(A)